The agreement frees the cash-strapped company from a potentially devastating one-time payment, but still requires Novavax to pay the vaccine alliance up to $475 million.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,